Flow cytometry has aided in new and significant approaches to oncology and hematology therapeutics, including immunotherapy treatments. In this final instalment of our Illuminating Flow Cytometry series, we focus on the use of flow cytometry in oncology clinical trials and how it may provide the basis for treatment selection in the future.